Although the overall consequences of acute DHODH inhibition on normal hematopoietic cells were minor in comparison with the effects observed on AML cells, they did indicate the potential for longer treatment regimens to cause therapy‐related toxicity including myelosuppression. The gene discussed is DHODH; the disease is acute myeloid leukemia.